Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Join UPhA
2017 Mid-Year Meeting
Share |

2016 Mid-Year Meeting

November 5, 2016
From 8:00am - 5:45pm


Thanksgiving Point
Amber Room
(Above the Museum of Ancient Life) 
3003 N Thanksgiving Way
Lehi, UT 84043


Thank you to all that attended! We had a great day of education with some of the best presenters in the profession. We look forward to seeing you at our next event in May 2017!

Agenda Presentation Topics:

  • Opioid Crisis in Utah: The Naloxone Good Samaritan Law - (0068-9999-16-016-L01-P/T)

    Dr. Mark Munger - Pharm.D.  Professor, Pharmacotherapy Univ of Utah
    1. Describe the opioid crisis in the United States and the State of Utah
    2. Summarize the toxidrome of opioid toxicity
    3. Recognize the signs and symptoms of opioid crisis
    4. Apply the steps in treatment of opioid crisis, monitoring for recovery, and how to transfer patient to urgent, emergent, or home care.
    5. Describe opioid and naloxone pharmacology, use in special populations, and administration technique.
    6. Explain the Naloxone Good Samaritan Law (Opiate Overdose Response Act Standing Orders and Other Amendments)
    7. Explain the Naloxone rules application to medicine and pharmacy.

Assessment info for this session was sent to attendees via email by the University of Utah on 11/15/2016. If you have not seen this email, please contact Shannon @ the UPhA office 801.438.2524
  • Ethical Responsibilities of Opioids - (0119-0000-16-037-L05-P/T)
    Bill Stilling, Parson Behle & Latimer.

 Apply two methods of resolving ethical issues.
Identify and describe the principles of pharmacy ethics that apply to scenarios involving the use of opioids.
Apply the principle of "Double Effect” to evaluate ethical issues involving opioids.
Describe the effect of implicit bias may have on ethical decisions involving opioids.
Identify and apply sections of laws and regulations that reference ethical standards.


  • Pharmacy Safety & Security - (0119-0000-16-035-L04-P/T) 

    Shane Tierman Associate Director Law Enforcement Liaison/Education Purdue Pharma L.P. 
    1. Identify intrusion detection systems, video surveillance/camera placement, physical design and internal controls.
    2. List techniques for appropriate response to a robbery or burglary
    3. List techniques to become a good witness and protect your patients, employees and yourself during stressful situations such as: Robberies, Burglaries, Forged/Altered Prescriptions, Fraudulent Call in Prescriptions
    4.Identify effective policies and procedures to address pharmacy crimes

  • New Drug and Immunization Update - (0119-0000-16-033-L01-P/T) 
    Dr. Jennifer Babin PharmD, Clinical Pharmacist, University Of Utah Hospital

    1. Describe the indications, mechanisms of action, and adverse effects of new drugs approved by the U.S. Food and Drug Administration (FDA) in 2016
    2. Analyze evidence for the use of drugs approved by the FDA in 2016
    3. Recognize 2016 drug safety labeling changes
    4. List recent Advisory Committee for Immunization Practices (ACIP) vaccine recommendations
    5. Address commonly asked questions about vaccines and vaccine hesitancy
    6. Describe safe vaccine administration techniques

  • Blood Pressure Management: A SPRINT to New HOPE  - (0119-0000-16-036-L01-P/T)

    Dr. Bonnie Kaminsky PharmD,Clinical Pharmacist, Heart Failure, Intermountain Medical Center
    1. Define blood pressure targets for various patient populations
    Compare and contrast the recently published "SPRINT” and "HOPE” landmark trials
    3. Select appropriate initial treatment options for management of high blood pressure
    4. Outline the pharmacists’ role in blood pressure management
    1. Define blood pressure targets for various patient populations
    2. Describe findings from the recently published "SPRINT” and "HOPE” landmark trials on blood pressure management
    3. Identify initial treatment options for the management of high blood pressure
    4. Outline the technicians’ role in blood pressure management

  • Keeping Your License in Good Standing - (0119-0000-16-038-L03-P/T)

    Panel Discussion: Jeff Gatzemeier Owner Oquirrah Mountain Pharmacy - UPhA Board Member; Lynn Hooper DOPL Investigator; Bill Stilling, Parson Behle & Latimer
    1. Identify ways to improve my compliance with state law
    Identify ways to improve my compliance with federal law
    3. Identify proper procedures on filling CII prescriptions
    4. List approved ID for validating customer identity

The Utah Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.            


The Utah Pharmacists Association is accredited by the Accreditation Council of Pharmacy Education as a provider of continuing pharmacy education. All credit will be issued 60 days following the event. 

CPE Monitor 

CPE Monitor is a collaborative system used by ACPE, the National Association of Boards of Pharmacy (NABP), and ACPE-accredited providers for all pharmacists and technicians to record and track their CPE credits. If you have not obtained your NABP e-Profile ID number, go to service/ to set up your e-Profile. If you have any questions about this service or your number, please contact NABP customer support at 847-391-4406, Monday to Friday between 9:00 pm and 5:00 pm CT. 

Target Audience 

UPhA education sessions are designed for pharmacists and pharmacy technicians from all practice settings. 

Courses appropriate for pharmacist participation are designated by an ACPE universal activity number ending in the letter "P.” 

Courses appropriate for pharmacy technician participation are designated by an ACPE universal activity number ending in the letter "T.”
Review the ACPE information for each session to determine the amount of credit offered. 

Session Handouts 

To help preserve our natural resources, UPhA education sessions are paperless. However, to offer participants an enduring reference to the education content, the majority of the presentation materials are available at These presentations will remain online until December 31, 2016. 

Activity Type

All activity types at this meeting are Knowledge Based activities.

Partial Credit 

UPhA does not offer partial credit for any CPE activity. 

Learning Objectives 

Learning objectives for all CPE sessions are provided here, on the UPhA website,,, in the program event guide, and are provided at the beginning of each session. 


Financial support for individual education sessions is indicated on handouts and noted at the beginning of each education session. Faculty disclosures are provided upon request. 

CPE Requirements 

To earn CPE credit for a session accredited by UPhA, participants must actively participate in the entire session, submit an attendance code, complete an activity evaluation, and "claim” your credit using the online CPE submission site. Proof of your CPE credit will be available to you on CPE Monitor. UPhA no longer issues paper statements of credit. 

All continuing pharmacy education (CPE) participation will be recorded online for 2016. Recording credit online is quick and easy! 

• You may record your CPE credit online at after the meeting until December 31, 2016. 

• You will need your username and password. If you need this information you can request it at the meeting registration desk or using the forgot password option on

• You will need your NABP e-Profile ID to allow the CPE credit to be transferred to the CPE Monitor system. You will need an attendance code for each session that you attended. These codes will be provided to you in each session. 

• You can print your CPE transcript directly from CPE Monitor. Individual statements of credit from UPhA are not available. 

Grievance Policy 

Should any attendee of an approved CPE session be dissatisfied with the quality of the activity, a request in writing must be submitted to the UPhA Education Department at within 5 days of the conclusion of the session. 

Community Search
Sign In
Sign In securely